Literature DB >> 10556861

Severe dementia: a common condition entailing high costs at individual and societal levels.

B Winblad, A Wimo, H J Möbius, J M Fox, L Fratiglioni.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10556861     DOI： 10.1002/(sici)1099-1166(199911)14:11<911::aid-gps66>3.0.co;2-i

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN： 0885-6230            Impact factor:   3.485


× No keyword cloud information.
  3 in total

Review 1.  Rivastigmine. A pharmacoeconomic review of its use in Alzheimer's disease.

Authors:  H M Lamb; K L Goa
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer's disease.

Authors:  Anders Wimo; Bengt Winblad; Albrecht Stöffler; Yvonne Wirth; Hans-Jörg Möbius
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 3.  For whom and for what the definition of severe dementia is useful: an EDCON consensus.

Authors:  E J Byrne; M Benoit; J M Lopez Arrieta; C Geraldi; R Koopmans; Y Rolland; N Sartorius; G Stoppe; P Robert
Journal:  J Nutr Health Aging       Date:  2008-12       Impact factor: 4.075
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.